An updated review of mesoporous carbon as a novel drug delivery system

Faculty Pharmacy Year: 2021
Type of Publication: ZU Hosted Pages: 1029-1037
Authors:
Journal: Drug Development and Industrial Pharmacy Taylor & Francis Volume: 47
Keywords : , updated review , mesoporous carbon , , novel drug    
Abstract:
The nanotechnology approach has been recently adopted to provide more reliable, effective, controlled, and safe drug delivery systems. Nanostructured materials have gained great interest, including siliceous and carbonaceous nanoparticles. The effectiveness of mesoporous carbon nanoparticles (MCNs) in tumor imaging, targeting, and treatment is urging for more future studies. MCNs possess superior properties such as their biocompatibility, large surface area, large pore volume, tunability, and more responsive behavior to internal and external release triggers. These outstanding features make MCNs more applicable for stimuli-responsive drug delivery than the conventional forms of mesoporous silica nanoparticles (MSNs) and other carbon nanoparticles. In this review, we outlined the latest updates regarding the safety, benefits, and potential applications of MCNs.
    
     
 
       

Author Related Publications

    Department Related Publications

    • Amr Selim Ahmed Ali Abu Lila, "A Novel Strategy to Increase the Yield of Exosomes (Extracellular Vesicles) for an Expansion of Basic Research", J-stage, 2018 More
    • Sherif Emam Abdallah Emam, "A Novel Strategy to Increase the Yield of Exosomes (Extracellular Vesicles) for an Expansion of Basic Research", J-stage, 2018 More
    • Mahmoud Abdalghany Mahmoud Mahdy, "A Novel Strategy to Increase the Yield of Exosomes (Extracellular Vesicles) for an Expansion of Basic Research", J-stage, 2018 More
    • Fakhreldeen Soliman Ghazy Shehata, "A Novel Strategy to Increase the Yield of Exosomes (Extracellular Vesicles) for an Expansion of Basic Research", J-stage, 2018 More
    • Abdelwahab Ali Hassan Ali Khidr, "Formulation, In Vitro Optimization and In Vivo Evaluation of Sustained Release Transdermal Patches of Venlafaxine Hydrochloride", Latin American Journal of Pharmacy, 2017 More
    Tweet